<span id="midArticle_start"/> Active Biotech Ab
<span id="midArticle_0"/>* Says focuses the operations on the laquinimod project andadjusts the organization
<span id="midArticle_1"/>* Active biotech AB says has made a notification of plannedredundancies of 47 of its employees, which means a significantdown-sizing of operations
<span id="midArticle_2"/> <span class="first-article-divide"/>* Says operating costs are expected to decrease toapproximately sek 50 million per year, from 2016
<span id="midArticle_3"/> <span class="second-article-divide"/>* Says planned organizational adjustment leads tosubstantially reduced operating costs
<span id="midArticle_4"/> <span class="third-article-divide"/>* Says comprehensive work remains to compile all data fromthe10TASQ10 study and to file the final study report to relevantregulatory authorities. This process is estimated to beconcluded during 2015.Source text for Eikon: Further company coverage: (Reporting By Daniel Dickson)
<span id="midArticle_5"/>
<span id="midArticle_0"/>* Says focuses the operations on the laquinimod project andadjusts the organization
<span id="midArticle_1"/>* Active biotech AB says has made a notification of plannedredundancies of 47 of its employees, which means a significantdown-sizing of operations
<span id="midArticle_2"/> <span class="first-article-divide"/>* Says operating costs are expected to decrease toapproximately sek 50 million per year, from 2016
<span id="midArticle_3"/> <span class="second-article-divide"/>* Says planned organizational adjustment leads tosubstantially reduced operating costs
<span id="midArticle_4"/> <span class="third-article-divide"/>* Says comprehensive work remains to compile all data fromthe10TASQ10 study and to file the final study report to relevantregulatory authorities. This process is estimated to beconcluded during 2015.Source text for Eikon: Further company coverage: (Reporting By Daniel Dickson)
<span id="midArticle_5"/>
via Smart Health Shop Forum http://ift.tt/1FOuhGu
No comments:
Post a Comment